First patients sought for groundbreaking cancer drug trial
Disease control
Not yet recruiting
This is the first study in people for a new type of cancer drug called ADCE-B05. It aims to find the safest and most effective dose for patients with advanced solid tumors that have stopped responding to standard treatments. Researchers will closely monitor how the body handles t…
Phase: PHASE1 • Sponsor: Adcendo ApS • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC